Recently, three gene therapy drugs have been approved for marketing, namely: (1) On July 21, 2022, PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that its AAV gene therapy Upstaza™ was approved by the European Commission It is the first marketed gene therapy directly in...
Read more